22nd Century Group (XXII) 17th Annual LD Micro Main Event Conference summary

Business overview and strategy

• Operates as a pure-play tobacco company with two revenue streams: branded low-nicotine products (VLN) and contract manufacturing for private labels.

• VLN is the only FDA-authorized, patented low-nicotine cigarette, positioned as a health-oriented alternative for nicotine control.

• Strategy shifted in 2024 to create a distinct low-nicotine category in retail, similar to decaf coffee or diet soda, aiming for greater visibility and consumer choice.

• Flanker brands are being introduced by encouraging contract manufacturing clients to add VLN SKUs to their product lines, expanding category presence.

• Targeting break-even by Q1 2025, requiring sales of 223,000 cartons annually, with current distribution in 5,100 outlets and plans to expand.

Market positioning and competitive landscape

• VLN offers a unique value proposition: one pack of VLN equals the nicotine of one regular cigarette, supporting harm reduction.

• No direct competitors for low-nicotine cigarettes; big tobacco controls 85% of the $84 billion U.S. market, while the company targets the $12.4 billion non-big tobacco segment.

• Regulatory barriers are low, with VLN in 26 states and contract manufacturing clients in 35 states; FDA approvals (MRTP, PMTA) facilitate expansion.

• Non-GMO tobacco strains now enable international sales, including markets like South Korea.

• Retailers are increasingly aligning with public health messaging, supporting the creation of a low-nicotine category.

Operations, R&D, and financials

• Five manufacturing lines support both branded and contract manufacturing, with the latter providing steady cash flow.

• R&D has produced patented low-nicotine tobacco through mutation, with ongoing work on new strains and product extensions (e.g., heat-not-burn, pouches).

• Collaboration with North Carolina State University strengthens R&D capabilities.

• Inventory includes $72 million in vacuum-sealed tobacco, ensuring freshness and no risk of obsolescence.

• Operating expenses have been significantly reduced, with EBITDA improving from a $20 million quarterly cash burn to a $1.4 million loss, targeting positive cash flow next quarter.